2021 American Transplant Congress
Thrombolytic Therapy During Ex-Vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury
*Purpose: A major limitation in expanding the use of DCD livers in transplantation are the higher rates of graft failure secondary to ischemic cholangiopathy. Warm…2021 American Transplant Congress
Comparative Proteomics Analysis Identifies the Biomarker of Ischemia-Reperfusion Injury During Liver Transplantation
*Purpose: To a large extent the success of liver transplantation depends on quality of allografts. The molecular basis of the susceptibility of different liver allografts…2021 American Transplant Congress
Delayed Valganciclovir Initiation and the Incidence of Cytomegalovirus Infection in Liver Transplant Recipients
Keck Medical Center of USC, Los Angeles, CA
*Purpose: Opportunistic infections remain a significant burden after liver transplantation, particularly cytomegalovirus (CMV) infection. With the use of valganciclovir (VGCV), the incidence of CMV infection…2021 American Transplant Congress
Predictive Factors of the Hepatic Artery Thrombosis in Liver Transplantation Through the Analysis of Donor Characteristics
*Purpose: Hepatic artery thrombosis (HAT) is one of the most severe complications after liver transplantation. It is treated as soon as possible to avoid irreversible…2021 American Transplant Congress
Hepatic Artery Thrombosis and Liver Transplantation: Patient Management and Candidate Selection for Re-transplantation
Baylor University Medical Center, Dallas, TX
*Purpose: Hepatic artery thrombosis (HAT) is a severe complication in liver transplantation (OLTX). Re-OLTX for patients with HAT has been met with controversy due to…2021 American Transplant Congress
Changes in Liver Transplant Volume and Induction During the Covid-19 Era
Washington University School of Medicine in St. Louis, Saint Louis, MO
*Purpose: The rapid spread and high infectivity of COVID-19 resulted in disruption of transplant procedures at many centers, including pauses in living donor transplantation and…2021 American Transplant Congress
Can an Organ Survive for More Than 100 Years Between Donor and Recipient
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: It has been hypothesized that parenchymal grafts have a longer life expectancy than the cardio-cerebro-vascular system. We investigated the occurrence of deceased-donor liver (DDOLT),…2021 American Transplant Congress
Liver Transplant in Adult Recipients Using Pediatric Deceased Donor Liver Grafts
*Purpose: The aim of this study is to evaluate the outcomes following liver transplantation (LT) in adults using grafts from a pediatric deceased donor.*Methods: A…2021 American Transplant Congress
Adult Deceased Donor Liver Transplantation with Split Liver Grafts vs Whole Liver Grafts. A Single-Center Experience
*Purpose: The present study aims to report outcomes of adults following SLT in a single-center and compare this selected group with adults recipients following whole…2021 American Transplant Congress
Role of Recovering Surgeon in DCD Liver Transplant Outcomes
*Purpose: Donation after cardiac death (DCD) liver transplant (LT) outcomes have continued to improve. Variability in outcomes has been attributed to center and recovering surgeon…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 20
- Next Page »